Quarterly report pursuant to Section 13 or 15(d)

Goodwill and Intangible Assets (Tables)

v3.22.0.1
Goodwill and Intangible Assets (Tables)
 6 Months Ended
Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets all in the life sciences products segment
    Gross     Accumulated Amortization     Net  
July 31, 2021   $ 27,775     $ (27,531 )   $ 244  
Amortization expense    
—
       (140 )     (140 )
Foreign currency translation     (216 )     212       (4 )
January 31, 2022   $ 27,559     $ (27,459 )   $ 100  

 
Schedule of intangible assets, all finite-lived
    January 31, 2022     July 31, 2021  
    Gross     Accumulated
Amortization		     Net     Gross     Accumulated
Amortization		     Net  
Patents   $ 11,027     $ (11,027 )   $
—
     $ 11,027       (11,027 )   $
—
  
Customer relationships     11,940       (11,840 )     100       12,059       (11,815 )     244  
Website and acquired content     1,019       (1,019 )    
—
       1,025       (1,025 )    
—
  
Licensed technology and other     488       (488 )    
—
       494       (494 )    
—
  
Trademarks     3,085       (3,085 )    
—
       3,170       (3,170 )    
—
  
Total   $ 27,559     $ (27,459 )   $ 100     $ 27,775       (27,531 )   $ 244  

 
Schedule of information with respect to acquired intangibles

 

   Useful life assigned   Weighted average
remaining useful life
Customer relationships   8 -15 years   0.5 years